Skip to main content
. 2014 Aug 5;2014:828137. doi: 10.1155/2014/828137

Table 2.

The global assessment to treatment of either Biobran or placebo.

Biobran (n = 19) Placebo (n = 20)
Markedly improved 4 (21.1%)∗ 2 (10.0%)
Slightly improved 8 (42.1%)∗ 4 (20.0%)

Unchanged 6 (31.6%) 11 (55.0%)
Not so good 1 (5.3%) 2 (10.0%)
Deteriorated 1 (5.0%)

*P = 0.0465 versus placebo.